Genmab AS (GMAB) — Net Asset Quality Index
Genmab AS (GMAB) has a Net Asset Quality Index of 45.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $12.84 Billion minus total liabilities of $7.01 Billion yields net assets of $5.83 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Genmab AS asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Genmab AS Net Asset Quality Index Over Time (2002–2025)
This chart shows how Genmab AS's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the index stands at 45.4%, representing net assets of $5.83 Billion against total assets of $12.84 Billion USD. See Genmab AS short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Genmab AS (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Genmab AS from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Genmab AS (GMAB) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 45.4% | $5.83 Billion | $12.84 Billion | $7.01 Billion | ▼ -34.7 pp |
| 2024 | 80.1% | $36.70 Billion | $45.81 Billion | $9.11 Billion | ▼ -9.5 pp |
| 2023 | 89.6% | $31.61 Billion | $35.29 Billion | $3.68 Billion | ▼ -1.0 pp |
| 2022 | 90.6% | $27.28 Billion | $30.12 Billion | $2.84 Billion | ▲ +0.5 pp |
| 2021 | 90.1% | $22.20 Billion | $24.63 Billion | $2.43 Billion | ▼ -0.3 pp |
| 2020 | 90.4% | $19.12 Billion | $21.14 Billion | $2.02 Billion | ▼ -2.3 pp |
| 2019 | 92.8% | $14.05 Billion | $15.14 Billion | $1.10 Billion | ▼ -2.0 pp |
| 2018 | 94.7% | $8.01 Billion | $8.46 Billion | $446.64 Million | ▼ -0.3 pp |
| 2017 | 95.0% | $6.27 Billion | $6.60 Billion | $330.75 Million | ▲ +2.8 pp |
| 2016 | 92.1% | $4.83 Billion | $5.24 Billion | $411.54 Million | ▲ +2.8 pp |
| 2015 | 89.3% | $3.49 Billion | $3.90 Billion | $415.83 Million | ▲ +18.4 pp |
| 2014 | 70.9% | $2.03 Billion | $2.87 Billion | $833.74 Million | ▲ +32.8 pp |
| 2013 | 38.1% | $659.52 Million | $1.73 Billion | $1.07 Billion | ▲ +15.5 pp |
| 2012 | 22.6% | $383.19 Million | $1.69 Billion | $1.31 Billion | ▼ -8.5 pp |
| 2011 | 31.1% | $486.42 Million | $1.56 Billion | $1.08 Billion | ▼ -12.4 pp |
| 2010 | 43.5% | $1.08 Billion | $2.48 Billion | $1.40 Billion | ▼ -14.9 pp |
| 2009 | 58.4% | $1.30 Billion | $2.22 Billion | $924.34 Million | ▼ -8.8 pp |
| 2008 | 67.2% | $2.19 Billion | $3.26 Billion | $1.07 Billion | ▼ -5.7 pp |
| 2007 | 72.8% | $2.88 Billion | $3.96 Billion | $1.08 Billion | ▼ -16.2 pp |
| 2006 | 89.1% | $1.61 Billion | $1.80 Billion | $197.05 Million | ▲ +7.4 pp |
| 2005 | 81.6% | $1.12 Billion | $1.37 Billion | $251.66 Million | ▼ -11.2 pp |
| 2004 | 92.9% | $1.18 Billion | $1.27 Billion | $90.92 Million | ▲ +0.8 pp |
| 2003 | 92.1% | $1.09 Billion | $1.18 Billion | $93.67 Million | ▲ +3.7 pp |
| 2002 | 88.4% | $1.40 Billion | $1.58 Billion | $183.97 Million | — |